Back to list

Randomized NKA Injection for DM II and CKD

University of North Carolina at Chapel Hill


To assess the safety and efficacy of up to two NKA injections given 6 months (+4 weeks) apart and delivered into the biopsied kidney using a percutaneous approach; and to assess the impact of NKA injection(s) on renal safety and function.


Diabetes, Kidneys


Drug or Biologic



30 - 80 years


Study Population

Adults, age 30-80 yrs old with Chronic Kidney disease due to Type 2 Diabetes Mellitus and established diagnosis of diabetic nephropathy as underlying cause of renal disease and NOT yet requiring dialysis.


Randal Detwiler
Distinguished Professor, Clinical Professor

For questions, contact:

Paula Steele
(919) 843-7829
Visit Website

Recruitment Period End

May 1, 2020


Primary Location
Clinical & Translational Research Center,
Burnett-Womack Building, 160 Dental Cir, Chapel Hill, NC 27514, USA
Secondary Location
UNC Hospital
101 Manning Dr, Chapel Hill, NC 27514, USA

Study Qualifications

Gender Any

Age Range 30 - 80 years

Participant qualification(s) Patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) with an estimated glomerular filtration rate (eGFR) between 20 and 50 mL/min/1.73m2 inclusive. Blood pressure must be controlled and less than 150/90.

Not eligible if: Prior kidney or organ transplant. Currently on dialysis. Uncontrolled diabetes (HgbA1C greater than 10%.).

Number of Visits

    » 30-40 In person visit(s)

    Visits will include Labs, ECGs, MRI, Renal US, Renal Scintigraphy for screening and follow-up. Once screening eligibility, subjects will receive a kidney biopsy. Renal NKA injections will require an overnight stay in UNC Hospitals.

    » 0 Remote visit(s)

Participation Period

36-48 Months


visa gift card per visit. Total dependent on treatment arm and visits completed.

By clicking I am interested, your contact information will be sent to the researcher/study coordinator for this study. The coordinator will respond by email with additional information on how to proceed.